retatrutide ly3437943 triple agonist gip glp-1 glucagon mechanism Beyond GLP -1: Retatrutide's triple-agonist (GLP-1, GIP, glucagon) is redefining metabolic health. Phase 2 data shows ~24% weight loss—surpassing semaglutide & tirzepatide. Evidence-based Pharmacotherapies under investigation based on

Key Benefits Measure oxidative stress at the source Evaluate your bodys antioxidant capacity and redox balance with the gold-standard GSH:GSSG ratio Track supplement effectiveness See whether NAC, alpha-lipoic acid, or glutathione supplementation is actually improving your antioxidant status Support detox and immune function Understand how well your body is neutralizing free radicals and eliminating toxins Guide anti-aging and longevity strategies Use objective data to assess cellular resilience and inform lifestyle changes Easy at-home collection Just a few drops of blood via finger-prick, no venous draw or clinic visit required What's Measured

Mills S, Candow DG, Forbes SC, Neary JP, Ormsbee MJ, Antonio J

Combining B12 Injections with a Healthy Lifestyle While B12 injections offer significant benefits, combining them with a healthy lifestyle can maximize their impact and ensure long-term wellness

Dietary intake of flavonoid subclasses and risk of colorectal cancer: evidence from population studies

Hazzaa SM, Abdou AG, Ibraheim EO, Salem EA, Hassan MHA, Abdel-Razek HAD (2021) Effect of L-carnitine and atorvastatin on a rat model of ischemia-reperfusion spinal cord injury

By activating these receptors in the brains satiety centers (like the area postrema), it promotes feelings of fullness, reduces food intake, and helps stabilize post-meal blood sugar spikes, making it a promising candidate for weight management, particularly in combination with the GLP-1 receptor agonist semaglutide (marketed as CagriSema)